Lake Street keeps Buy rating on Insight Molecular and cuts target to $9
Lake Street kept its Buy rating on Insight Molecular but lowered the price target by 25%, from $12 to $9, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Lake Street kept its Buy rating on Insight Molecular shares but reduced the price target from $12 to $9, a 25% cut. The information comes from TradingView, which cites reference data provided by Benzinga.
Based on the November 19 close of $1.66, the new target implied an upside of 442.2% from that level.
why it matters
Price target revisions on individual stocks are routine for small-cap markets. A single analyst target change rarely moves a share price on its own, so the company's broader performance and news flow matter more.
tags
instruments
sources
- Lake Street maintains Insight Molecular at Buy, lowers price target to $9 from $12 — TradingView, 20 November 2026 at 19:14 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗